89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer (Q63229507)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer |
clinical trial |
Statements
89Zirconium-labeled Pembrolizumab as Predictive Imaging Biomarker of Response and Toxicity in Pembrolizumab Treated Patients With Non-small-cell Lung Cancer - a Feasibility Study (English)
0 references
20 January 2017
0 references
1 December 2019
0 references
10
0 references
18 year
0 references